Occult occupational infection with Mycoplasma fermentans has been proposed as a cause for illness among Persian Gulf War veterans. Symptom data and sera from a 1994-1995 cross-sectional survey of Navy Seabees were used to select symptomatic and asymptomatic Gulf War veterans and nondeployed veterans to evaluate this hypothesis. Survey sera from 96 Seabees were matched to prewar (before September 1990) archived sera. Immunoblot serologic analyses were performed for M. fermentans in a controlled, blinded fashion. Both Gulf War veterans and nondeployed veterans had prewar and postwar serologic evidence of M. fermentans infection consistent with natural infection data. Among study subjects collectively, and stratified by Gulf War service, none of the immunoblot banding profiles (prewar or postwar) or their changes over time were associated with postwar symptoms. These serologic data do not support the hypothesis that Gulf War veterans have experienced Gulf War-related morbidity from M. fermentans infection.
There has been much speculation and concern 1-6 that the increased reporting of symptoms [7] [8] [9] by veterans of the Persian Gulf War may be due to a mysterious infectious disease process. The Gulf War theater, 10 located on and about the Arabian Peninsula, was a desert environment with numerous recognized infectious disease threats 11, 12 foreign to many of the 697,000 deployed U.S. military personnel. Additionally, Iraq had an extensive biological and chemical weapon development program and had used weapons of mass destruction domestically and in a war with Iran. [13] [14] [15] [16] Aggressive preventive measures, 17, 18 and the deployment of a sophisticated field laboratory 19 in the theater of operations provided substantial infectious disease morbidity data during the conflict, which essentially ended in 1991. 17, [19] [20] [21] [22] [23] [24] [25] [26] These data reveal that U.S. forces experienced diarrheal, [21] [22] [23] [24] respiratory, 24, 27 and parasitic infections, 27 although the incidence was much lower than expected. 17 Additional medical data were collected after the war, when the Departments of Defense and Veterans Affairs conducted more than 100,000 comprehensive clinical evaluations of veterans and their families. 5, 28 However, other than the 12 U.S. Gulf War veterans who developed viscerotropic leishmaniasis, 6, [29] [30] [31] [32] no other new infectious disease processes have been recognized as explanations for increased symptom reporting. [4] [5] [6] 33 Although there has been much discussion about Iraq's weapon program, 16, 34 expert review panels have agreed that it is unlikely that Iraq used biological weapons in the Gulf War. 3, 35 In addition to endemic infectious disease and biological weapon threats, other infectious disease hypotheses have been speculated, including Epstein-Barr virus infections, 36 mycotoxin poisoning, 37 cryptic streptococcal infection, 4 and microsporidia infection. 4 Perhaps the most provocative of these speculations has been the suggestion that a genetically altered form of Mycoplasma fermentans was clandestinely used as a biological agent during the Persian Gulf War. [38] [39] [40] [41] [42] [43] [44] Allegations of U.S. government involvement in the purported biological agent's development have astounded and concerned the public. [45] [46] [47] These reports have won a number of veteran advocates and have spawned a cottage industry of special laboratory testing (classified as research testing and not regulated) to aid Gulf War veterans in their diagnosis and treatment.
The purpose of this research was to test the hypothesis that symptomatic Gulf War veterans have serologic evidence of M. fermentans infection.
SUBJECTS, MATERIALS AND METHODS
Study population and paired sera selection. The study population and symptom analyses are described elsewhere. 9 Briefly, during 1994 and 1995, a cross-sectional survey of Navy construction workers (Seabees) who had remained on active duty since the Persian Gulf War was performed. After granting informed consent, 527 Gulf War veterans and 970 nondeployed veterans from 14 Seabee commands participated. In addition to answering questions regarding present and past symptoms, participants donated sera that was matched to banked (before September 1990) sera obtained from an Army-Navy human immunodeficiency virus serum repository. Many of the study subjects, especially those who had served in the Gulf War theater, complained of chronic nonspecific symptoms since the Gulf War.
Subjects were studied for the self-reported prevalence of one month or more (since July 1990) of 46 symptoms. For the purposes of this study, participants were screened by their responses to seven of these symptom questions that were most consistent with clinical reports of mycoplasmal infection: cough, sore throat, pains that move from one joint to another, joint swelling, joint redness, rash or skin ulcer, fever, and asthma. [48] [49] [50] After selecting the most symptomatic subjects first and other subjects with a random-number procedure, 90 Gulf War veterans (60 symptomatic) and 60 nondeployed veterans (30 symptomatic) were identified. Only those whose prewar sera were available were studied for evidence of M. fermentans infection: symptomatic Gulf War veterans (n ϭ 46), asymptomatic Gulf War veterans (n ϭ 18), symptomatic nondeployed veterans (n ϭ 20), and asymptomatic nondeployed veterans (n ϭ 12). Three of these 96 Seabees were women. This study was conducted in accordance with the Department of the Navy's Protection of Human Subjects guidelines.
Laboratory procedures. Sera were shipped on dry ice to the University of Alabama Diagnostic Mycoplasma Laboratory (Birmingham, AL). Laboratory staff were blinded with respect to each patient's Gulf War experience and postwar symptoms.
Antigen preparation, sodium dodecyl sulfate-polyacrylamide gel electrophoresis, and Western blot analysis were performed as described elsewhere. 51 Briefly, proteins from M. fermentans strains incognitus, DEB, 17065, MT-2, K-7, PG-18, and AOU were separated by electrophoresis using 10% resolving and 4% stacking gels. Separated proteins were transferred for immunoblotting to nitrocellulose sheets (Bio-Rad, Hercules, CA) according to the method of Towbin and others. 52 Immunologic reactions using patient serum diluted 1:100 were visualized with peroxidase-labeled conjugates (Sigma, St. Louis, MO). Sera were classified as immunoblot negative if no reactive antigens were detected and as immunoblot positive if at least one antigen was detected. Reactions were subjectively scored as weak positive based on the intensity of the reaction relative to a positive reaction ( Figure 1 ). For statistical analyses, only positive reactions were considered evidence for M. fermentans infection. If a subject's prewar sera was negative or weak and his postwar survey sera was positive, he was considered to have evidence of a new M. fermentans infection since the war. Positive reactions were further stratified into reactions positive with 30-kD antigens, 60-kD antigens, both 30-kD and 60-kD antigens, or a mixture of three or more different antigens.
As a possible source of confounding for the M. fermentans assays, the serologic responses (IgM and IgG) to M. pneumoniae were also determined using an ELISA. [53] [54] [55] A whole cell lysate antigen was used to maximize sensitivity. Positive and negative controls were also used. A positive M. pneumoniae serologic result was defined as either a four-fold increase in IgM or IgG titers or a change in IgM titer from negative to elevated. A subject's IgM response greater than the threshold value of 1:10 (derived from a group of control subjects' sera) was considered elevated.
Statistical analyses. Univariate risk factor associations were examined using the chi-square test or Fisher's exact test. Exact confidence intervals 56 were calculated about unadjusted odds ratios.
RESULTS
Gulf War veterans and nondeployed veterans were similar with respect to race, marital status, gender, postwar hospitalizations, and symptom reporting (Table 1 ). However, Gulf War veterans were slightly younger and less well educated than their nondeployed peers. These findings were consistent with findings from other studies of morbidity among Gulf War veterans. 57, 58 Examples of the immunoblot analyses are shown in Figure  1 . Variations of the antibody reactivity patterns included no reaction for prewar or postwar sera, reaction for either prewar or postwar sera, and reactions for both prewar and postwar sera. The positive examples included in Figure 1 show paired sera that demonstrated some degree of reaction from both prewar and postwar sera.
Immunoblot testing of paired sera revealed that seven (10.9 %) of 64 Gulf War veterans and three (9.3%) of 32 nondeployed had prewar antibody against M. fermentans. Serologic testing of the study subjects without prewar antibody revealed that 11 (19.2%) of the 57 Gulf War veterans and four (13.7%) of the 29 nondeployed veterans had serologic evidence of new M. fermentans infection since the war ( Table 2) . Given these serologic results, individuals were then examined by symptom reporting. Four (14.2%) of 28 asymptomatic subjects (both Gulf War veterans and nondeployed veterans) and 11 (19.0%) of 58 symptomatic subjects had evidence of new M. fermentans infection ( Table 2 ). We then stratified by deployment status and symptom reporting. Three (17.6%) of 17 asymptomatic Gulf War veterans and one (9.1%) of 11 asymptomatic nondeployed veterans demonstrated serologic evidence of new M. fermentans infection (Table 3) . Similarly, eight (20%) of 40 symptomatic Gulf War veterans and three (16.7%) of 18 symptomatic nondeployed veterans had serologic evidence of new M. fermentans infection ( Table 3 ). None of these comparisons was statistically significant.
Additionally, among study subjects collectively, and stratified by Gulf War service, none of the specific immunoblot banding profiles (prewar or postwar) or their changes over time were statistically associated with postwar symptoms.
Finally, there was little indication that M. fermentans serologic analyses were confounded by M. pneumoniae infection. Only one individual (asymptomatic nondeployed veteran) had evidence of new infection with both M. fermentans and M. pneumoniae over the time period of study.
DISCUSSION
Although M. fermentans has been recovered from the urogenital and respiratory tract, bone marrow, and joints of patients, [59] [60] [61] [62] little consideration was given to the possibility that this organism was a human pathogen until the description of an organism tentatively named M. incognitus. It was originally reported in patients with acquired immunodeficiency syndrome (AIDS) and was later found in non-AIDS patients. 49, 63, 64 Genetic and serologic comparisons subsequently confirmed that the organism originally designated as M. incognitus was a strain of M. fermentans. 65 Nicolson and Rosenberg-Nicolson have suggested that mycoplasmas might be the cause of postwar morbidity among Gulf War veterans. 38 Since then, Nicolson and Nicolson have reported identifying occult mycoplasmal infection with a gene-tracking and forensic polymerase chain reaction technique and successfully treating symptomatic veterans with long courses of doxycycline and other antibiotics. 66 They suggest that Gulf War veterans are transmitting mycoplasmas via close contact with their family members. They argued that the pathogen, M. fermentans (incognitus strain), is intracellular and often fails to cause a humoral immunogenic response, and that only their laboratory and properly trained laboratories can detect the pathogen. 67 Although validation studies are in progress, these experimental laboratory procedures have not yet been properly corroborated and the efficacy of clinical treatments have not been evaluated with appropriate clinical trials.
Mycoplasmal organisms cause a wide range of diseases, are suspected in others, are particularly aggressive in immunocompromised individuals, and the infections are characteristically chronic. Due to the difficulty of detection by culture, these organisms are likely to be grossly underdiagnosed. At least some individuals may harbor the organisms with little or no signs of illness. Furthermore, there often is a remarkable degree of variability in pathogenicity among different strains of the same organism. 68 In most instances, when disease does occur, the host response is an integral part of lesion development. With the exception of certain diseases of animals, mycoplasmal diseases are rarely fatal and often clinically silent. 68 Conversely, the host is seldom capable of quickly eliminating the organism. 68, 69 For example, M. pulmonis infection of rodents can persist for the life of the host even in the presence of an intense inflammatory and immune response and it ultimately may result in chronic obstructive lung disease and contribute to death. 68 In hu- mans, Ureaplasma urealyticum infection can persist in the joint synovial fluid of immunocompromised individuals for up to two years producing a slowly progressive, chronic arthritis. 65 Animal model studies have shown that stress from environmental factors and microbial synergy can result in exacerbation of infection to a clinically significant disease. The percentage of clinically insignificant human infections that may respond similarly to stress factors is unknown. Thus, in a population that is inherently stressed by a multitude of physical and psychologic factors, such as military troops in a war zone, it would not be unexpected to find that such organisms play a significant role in the production of various clinical symptoms.
Since mycoplasma infections are so often clinically silent it is of importance to evaluate antibody responses in patients with and without disease. This will help to discern if the quality of an anti-mycoplasmal antibody response is reflective of active disease or, conversely, if one antibody response is protective compared with another. This type of analysis is most easily performed using immunoblot analyses since specific reactive antigens can be discerned, whereas ELISA techniques do not currently have such precision. Here we have examined reactions to numerous specific M. fermentans antigens for associations with postwar symptoms. It is inter-esting in this study that for serum pairs where there was some reaction in both prewar and postwar sera, the antigens recognized were the same. This may indicate that the immune systems of certain individuals are primed to respond to specific antigens.
Although our analyses provide evidence that M. fermentans does not have a significant role in the illnesses reported by Gulf War veterans, our findings must be interpreted with caution. Our statistical power to detect small differences was limited by the sample size. For example, using commonly accepted parameters (␣ ϭ 0.05, ␤ ϭ 0.20), we had only enough subjects to detect an odds ratio of approximately 5.0 when we compared all Gulf War veterans (n ϭ 57) with nondeployed veterans (n ϭ 29) for seroconversions. Such power would have been quite adequate had we detected what was suggested by others since there were almost no seroconversions among nondeployed veterans and many seroconversions among Gulf War veterans. 67 Additionally, our data are limited in that due to small sample sizes, we could not adjust for potential confounders, such as age. However, except for age and education, the study populations were homogeneous with respect to demographic characteristics and other potential confounders ( Table 1 ). We argue that the small difference in age is not likely to be biologically important.
Because of the long time period between paired sera and the lack of clinical and antibiotic use data, our serologic results likely underestimate the true incidence of infection. However, if Gulf War veterans had postwar symptoms due to active M. fermentans infection, one would expect to detect a higher prevalence of positive reactions among postwar sera for the most symptomatic Gulf War veterans. This has been alleged by a few scientists, citing positive gene-tracking results in 14 (46.7%) of 30 symptomatic Gulf War veterans in an uncontrolled study. 67 Our data demonstrate no such high postwar prevalence of M. fermentans reactions, nor statistically important changes in immunoblot reaction over time among symptomatic or asymptomatic Gulf War veterans.
Much uncertainty remains concerning the etiology of postwar symptoms among Gulf War veterans. Certainly, there is a marked difference between Gulf War veteran and nondeployed veteran symptom reporting. [7] [8] [9] This difference is likely due to multiple causes, including postwar stress. 6, 70 However, we agree with expert panels that doubt the M. fermentans hypothesis as a cause for increased postwar morbidity. 4, 6, 71 These data are consistent with several large epidemiologic studies of postwar hospitalizations, which have not found evidence of emerging infectious disease. 57, 58 Our findings are important to Gulf War veterans, providing evidence that M. fermentans infections occurred both before and after the war, and that these infections occur in military populations independent of deployment to the Persian Gulf theater. 10 These serologic data do not support the hypothesis that Gulf War veterans have experienced Gulf War-related morbidity from M. fermentans infection.
